新的GNAS-Gsα变体 (p.Thr55Ala) 对AVPR2和PTH1R信号产生构成性功能的效应
Maiko Ikeda1, Chikahiko Numakura2,3, Gen Nishimura4
1Department of Pediatrics, Hamamatsu University School of Medicine, Hamamatsu, Japan.
Journal of human genetics
|January 13, 2026
概括
GNAS-Gsα变种导致罕见的遗传疾病,如不适当的抗尿路症 (NSIAD) 的神经性综合征和骨病. 一种新的变异,p.Thr55Ala,显示了功能的增加和功能丧失效应,影响受体信号传递.
科学领域:
- 内分泌学 在内分泌学.
- 遗传学 遗传学 是一个
- 分子生物学分子生物学
背景情况:
- GNAS-Gsα变体可以导致构成性联体独立的功能增益 (GOF) 效应.
- 这些变体与不适当的抗尿路症 (NSIAD) 的原性综合征,骨解质性骨障碍和早熟青春期有关.
研究的目的:
- 在患有NSIAD和骨解性骨障碍的患者中研究一种新的GNAS-Gsα变异.
- 为了阐明所识别的GNAS-Gsα误解变体 (p.Thr55Ala) 的功能后果.
主要方法:
- 全基因组测序以确定遗传变异.
- 路西法酶测定评估GNAS-Gsα变异信号.
- 蛋白质结构分析以了解变异机制.
主要成果:
- 在一个患有NSIAD和骨障碍的日本女孩身上发现了一种新异构的GNAS-Gsα误解变体 (p.Thr55Ala).
- 这种p.Thr55Ala变体在AVPR2和PTH1R信号传递上表现出对体独立的GOF效应.
- 该变体还表现出在PTH1R信号传递上依赖带的功能丧失 (LOF) 和减少的核酸结合亲和力.
结论:
- 具有构成GOF影响的GNAS-Gsα变体有助于临床上明显的先天性罕见疾病.
- p.Thr55Ala变体的双重GOF/LOF效应提供了关于GNAS相关疾病的见解.
- 这项研究加强了GNAS变异在NSIAD和特征性骨疾病中的作用.
更多相关视频
相关概念视频
The Ras Gene
7.0K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
7.0K
GPCRs Regulate Adenylyl Cylase Activity
7.3K
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
7.3K
Activation and Inactivation of G Proteins
10.9K
Heterotrimeric G proteins are guanine nucleotide-binding proteins. As the name suggests, heterotrimeric G proteins are composed of three subunits: alpha, beta, and gamma. They remain GDP-bound or GTP-bound inside the cells and switch between inactive/active states. The Gα subunit possesses the nucleotide-binding pocket that binds guanine nucleotides and switches between GDP or GTP-bound states. In contrast, the Gꞵ and Gγ subunits are always bound together with high...
10.9K
GPCR Desensitization
7.9K
G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
7.9K
TGF - β Signaling Pathway
10.5K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.5K
Transducer Mechanism: Enzyme-Linked Receptors
3.9K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
3.9K


